“Brain diseases are poorly understood, and they receive less investment into drug development and patient care. ‘This is aggravated by the fact that the majority of brain diseases are affecting the female population worldwide.'”
-Dr Antonella Santuccione Chadha, Women’s Brain Project CEO and Co-founder
The Women’s Brain Project (WBP), as the world experts in the field of sex (biological) and gender (societal) determinants of brain and mental health to achieve precision medicine and care, commissioned Economist Impact to examine the economic rationale for investing in sex-and-gender specific brain research.
